soliqua insulin glargine (rbe) 100 units/ml and lixisenatide 33 microgram/ml solution for injection injector pen
sanofi-aventis australia pty ltd - insulin glargine,lixisenatide -
soliqua insulin glargine (rbe) 100 units/ml and lixisenatide 50 microgram/ml solution for injection injector pen
sanofi-aventis australia pty ltd - insulin glargine,lixisenatide -
polivy
roche products (nz) ltd - polatuzumab vedotin 140mg - powder for injection - 140 mg - active: polatuzumab vedotin 140mg excipient: polysorbate 20 sodium hydroxide succinic acid sucrose - polivy in combination with rituximab, cyclophosphamide, doxorubicin and prednisone (r-chp), is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma. polivy in combination with bendamustine and rituximab is indicated for the treatment of previously treated adult patients with diffuse large b-cell lymphoma who are not candidates for hematopoietic stem cell transplant.
nuan gong cheng yun fang a.k.a. motherhood formula
sun herbal pty ltd - angelica polymorpha,astragalus membranaceus,atractylodes macrocephala,cinnamomum cassia,codonopsis pilosula,curcuma longa,cuscuta hygrophilae,cyperus rotundus,epimedium sagittatum,glycyrrhiza uralensis,ligusticum wallichii,lycium barbarum,paeonia -
amoxil forte sugar free syrup amoxicillin 250 mg/5 ml (as trihydrate) powder for oral liquid bottle
aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 57.4 mg/ml - oral liquid, powder for - excipient ingredients: silicon dioxide; sorbitol; saccharin sodium; colloidal anhydrous silica; sodium benzoate; xanthan gum; disodium edetate; flavour - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli (see microbiology). respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbiology), p.mirabilis and s.faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxil may be used for the prophylaxis
amoxil sugar free syrup amoxicillin 125 mg/5 ml (as trihydrate) powder for oral liquid bottle
aspen pharmacare australia pty ltd - amoxicillin trihydrate, quantity: 28.7 mg/ml - oral liquid, powder for - excipient ingredients: colloidal anhydrous silica; disodium edetate; xanthan gum; saccharin sodium; sodium benzoate; sorbitol; silicon dioxide; flavour - it is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms: note therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure: staphylococcus, non-penicillinase producing; streptococcus; e.coli (see microbiology). respiratory (acute and chronic): h.influenzae, streptococcus; s.pneumoniae; staphylococcus, non-penicillinase-producing; e.coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic): e.coli (see microbiology), p.mirabilis and s.faecalis. gonorrhoea: n.gonorrhoeae (non-penicillinase producing). prophylaxis of endocarditis: amoxil may be used for the prophylaxis
med-olmesartan tablet
generic medical partners inc - olmesartan medoxomil - tablet - 20mg - olmesartan medoxomil 20mg - angiotensin ii receptor antagonists
med-olmesartan tablet
generic medical partners inc - olmesartan medoxomil - tablet - 40mg - olmesartan medoxomil 40mg - angiotensin ii receptor antagonists
med-moxifloxacin tablet
generic medical partners inc - moxifloxacin (moxifloxacin hydrochloride) - tablet - 400mg - moxifloxacin (moxifloxacin hydrochloride) 400mg - quinolones
med-voriconazole tablet
generic medical partners inc - voriconazole - tablet - 200mg - voriconazole 200mg - azoles